Brexpiprazole
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 563 publications
Dextromethorphan/bupropion (Auvelity) for agitation in Alzheimer's dementia.
Journal: The Medical letter on drugs and therapeutics
Published: June 15, 2026
Benefits and safety of brexpiprazole in adolescents living with schizophrenia: a plain language summary.
Journal: Current medical research and opinion
Published: June 09, 2026
Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.
Journal: International clinical psychopharmacology
Published: May 28, 2026
Letter: Outcome Measure Selection as a Source of Null Results in Autism Pharmacotherapy: The Case of Brexpiprazole and the ABC-I.
Journal: Journal of child and adolescent psychopharmacology
Published: May 21, 2026
Methodological considerations on the network meta-analysis of brexpiprazole dosing for agitation in Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: May 08, 2026
Efficacy of Antipsychotic Augmentation Therapy in Treatment-Resistant Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis.
Journal: Cureus
Published: May 06, 2026
Optimizing outcomes in major depressive disorder.
Journal: The Nurse practitioner
Published: April 23, 2026
Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer's disease.
Journal: Expert opinion on pharmacotherapy
Published: April 21, 2026
Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.
Journal: Schizophrenia (Heidelberg, Germany)
Published: April 03, 2026
Last Updated: 06/30/2026